PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person)
ApprovedActive 0 watching 0 views this week🔥 Hot
80
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
H. Pylori Infection
Conditions
H. Pylori Infection, Gastric Cancer, Gastritis H Pylori
Trial Timeline
Nov 6, 2024 → Nov 6, 2027
NCT ID
NCT07224048About PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person)
PYTEST® 14C-Urea Capsule Breath Test (at Home) + PYTEST® 14C-Urea Capsule Breath Test (Standard Retesting In-Person) is a approved stage product being developed by Phathom Pharmaceuticals for H. Pylori Infection. The current trial status is active. This product is registered under clinical trial identifier NCT07224048. Target conditions include H. Pylori Infection, Gastric Cancer, Gastritis H Pylori.
Hype Score Breakdown
Clinical
30
Activity
20
Company
5
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07224048 | Approved | Active |
Competing Products
7 competing products in H. Pylori Infection
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy | Sun Pharmaceutical | Approved | 85 |
| Rabeprazole Sodium | Eisai | Pre-clinical | 23 |
| helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine | Novartis | Phase 1 | 33 |
| H.pylori vaccines + Placebo Vaccine | Novartis | Phase 1 | 33 |
| Vonoprazan + Amoxicillin + Clarithromycin + Lansoprazole | Phathom Pharmaceuticals | Phase 3 | 72 |
| PYTEST® 14C-Urea Breath Test + VOQUEZNA® Triple Pak® | Phathom Pharmaceuticals | Approved | 80 |
| RHB-105 + Active Comparator | RedHill Biopharma | Phase 3 | 69 |